Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Prevention and Treatment of OHSS
NCT03794037Phase 2Suspended
- Sponsor
- Benha University
- Start
- Dec 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of montelukast in ovarian hyperstimulation syndrome (OHSS), sponsored by Benha University. Primary endpoint: Number of Participants who develop ovarian hyperstimulation syndrome at 14 days. Started Dec 2018; status: suspended.
02
Drugs
montelukast
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT03794037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03794037.